Cargando…

Defibrotide for hepatic veno-occlusive disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2021
Materias:	New Drugs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075747/ https://www.ncbi.nlm.nih.gov/pubmed/33911337 http://dx.doi.org/10.18773/austprescr.2021.010

Ejemplares similares

Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016)

Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
por: Kong, Seom Gim, et al.
Publicado: (2022)

Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study
por: Mohty, Mohamad, et al.
Publicado: (2022)

Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome
por: Kernan, Nancy A., et al.
Publicado: (2018)

Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with Defibrotide
por: Castellino, Alessia, et al.
Publicado: (2018)

Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
por: Nauffal, Mary, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
por: Corbacioglu, Selim, et al.
Publicado: (2022)

A case report of severe veno-occlusive disease following autologous stem cell transplantation successfully treated with Defibrotide
por: Bahoush, Golamreza, et al.
Publicado: (2020)

Publisher Correction: Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019)

Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
por: Richardson, Paul G., et al.
Publicado: (2020)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report
por: Lee, Tae Beom, et al.
Publicado: (2021)

Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment
por: Richardson, Paul G., et al.
Publicado: (2020)

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients
por: Corbacioglu, Selim, et al.
Publicado: (2020)

A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting
por: Tappe, William, et al.
Publicado: (2020)

Pooled analysis of Day 100 survival for defibrotide‐treated patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation
por: Richardson, Paul G., et al.
Publicado: (2020)

Opicapone for Parkinson’s disease
Publicado: (2023)

Trientine dihydrochloride for Wilson’s disease
Publicado: (2021)

Erratum to “A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting”
Publicado: (2020)

Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
Publicado: (2019)

Finerenone for chronic kidney disease associated with type 2 diabetes with albuminuria
Publicado: (2023)

Treosulfan for acute myeloid leukaemia and myelodysplastic syndrome in adults, and malignant and non-malignant haematological diseases in children
Publicado: (2023)

HIV-related Pneumocystis jirovecii pneumonia managed with caspofungin and veno-venous extracorporeal membrane oxygenation rescue therapy
por: Lee, Nathaniel, et al.
Publicado: (2017)

Siponimod for multiple sclerosis
Publicado: (2021)

Cinnarizine/dimenhydrinate for vertigo
Publicado: (2021)

Selexipag for pulmonary arterial hypertension
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Ozanimod for multiple sclerosis
Publicado: (2021)

ChAdOx1-S vaccine for prevention of COVID-19
Publicado: (2021)

Trifarotene for acne
Publicado: (2021)

Tafamidis and tafamidis meglumine for amyloid cardiomyopathy
Publicado: (2021)

Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
Publicado: (2021)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Sotrovimab for COVID-19
Publicado: (2021)

Elasomeran for prevention of COVID-19
Publicado: (2021)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Voretigene neparvovec for inherited retinal dystrophy
Publicado: (2021)

Lurbinectedin for small cell lung cancer
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_snhc1qr6nlfpv79scviatrgfm5